In Blunt Response, Open Biosystems Defends Itself Against Sigma-Aldrich Suit | GenomeWeb

NEW YORK, June 15 (GenomeWeb News) - Open Biosystems today responded to a patent-infringement suit filed against it by Sigma-Aldrich and Oxford BioMedica, framing the dispute in David vs. Goliath terms.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.